On January 20, 2020, the National Health Commission of the People's Republic of China issued the No. 1 document of 2020, which officially incorporated the 2019 novel coronavirus (2019-nCoV) infected pneumonia into the Class B infectious diseases specified in the Law of the People's Republic of China on the Prevention and Treatment of Infectious Diseases, and adopted the Class A infectious

Novel coronavirus pneumonia (NCP) is an acute infectious pneumonia. The 2019 novel coronavirus, which is highly infectious, and has been rapidly spreading to the world by the end of 2019 and beginning of 2020. Countries and regions, causing serious psychological panic among the people in the epidemic area, so this article uses crawler to obtain novel coronavirus post bar data for public opinion an

Objective To explore changes in disease burden of viral encephalitis (VE) in China between 1990 and 2019 and compare this with the global situation over the same period, so as to provide direc-tion for effective prevention and control strategies. Method  Based on the data from the Global Burden of Diseases 2019 survey (GBD 2019), the incidence, prevalence, mortality, years lived with dis

Inflammatory bowel disease (IBD) is a chronic and progressive disease which is currently hard to cure. Traditional treatments, such as aminosalicylates, steroids and immunosuppressants, can only alleviate symptoms, but can’t prevent potential inflammation or change the disease progress. The application of biological agents represents a turning point in the treatment of IBD. With the expansion of r

Inflammatory bowel disease (IBD) refers to a group of chronic non-specific inflammatory bowel diseases with unclear etiology, mainly including ulcerative colitis (UC) and Crohn's disease (CD), which are characterized by recurrent attacks, persistence and non-healing of lesions. At present, the diagnosis lacks a gold standard and mainly relies on the comprehensive judgment of clinical manifesta